Literature DB >> 25965350

Contact dermatitis: a practice parameter-update 2015.

Luz Fonacier, David I Bernstein, Karin Pacheco, D Linn Holness, Joann Blessing-Moore, David Khan, David Lang, Richard Nicklas, John Oppenheimer, Jay Portnoy, Christopher Randolph, Diane Schuller, Sheldon Spector, Stephen Tilles, Dana Wallace.   

Abstract

This parameter was developed by the Joint Task Force on Practice Parameters, which represents the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma & Immunology. The AAAAI and the ACAAI have jointly accepted responsibility for establishing "Contact Dermatitis: A Practice Parameter-Update 2015." This is a complete and comprehensive document at the current time. The medical environment is changing and not all recommendations will be appropriate or applicable to all patients. Because this document incorporated the efforts of many participants, no single individual, including members serving on the Joint Task Force, are authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information or interpretation of this practice parameter by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by the pharmaceutical industry in drug development or promotion. Previously published practice parameters of the Joint Task Force on Practice Parameters for Allergy & Immunology are available at http://www.JCAAI.org or http://www.allergyparameters.org.
Copyright © 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergic contact dermatitis; allergen; contact dermatitis; guideline; occupational; parameter; patch testing; sensitizer

Mesh:

Year:  2015        PMID: 25965350     DOI: 10.1016/j.jaip.2015.02.009

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  13 in total

Review 1.  Diagnosing and managing drug allergy.

Authors:  Elissa M Abrams; David A Khan
Journal:  CMAJ       Date:  2018-04-30       Impact factor: 8.262

Review 2.  Allergy to Local Anesthetics is a Rarity: Review of Diagnostics and Strategies for Clinical Management.

Authors:  Shirley Jiang; Monica Tang
Journal:  Clin Rev Allergy Immunol       Date:  2022-04-28       Impact factor: 8.667

3.  Contact dermatitis: Clinical practice findings from a single tertiary referral hospital, a 4-Year retrospective study.

Authors:  Giovanni Sedó-Mejía; Andrés Soto-Rodríguez; Caridad Pino-García; Alfredo Sanabria-Castro; Olga Patricia Monge-Ortega
Journal:  World Allergy Organ J       Date:  2020-08-11       Impact factor: 4.084

Review 4.  Adverse Effects of Nonsystemic Steroids (Inhaled, Intranasal, and Cutaneous): a Review of the Literature and Suggested Monitoring Tool.

Authors:  Ratika Gupta; Luz S Fonacier
Journal:  Curr Allergy Asthma Rep       Date:  2016-06       Impact factor: 4.806

5.  Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?

Authors:  Rannakoe J Lehloenya; Jonny G Peter; Ana Copascu; Jason A Trubiano; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2020-10

Review 6.  Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America.

Authors:  C Mayorga; P Bonadonna; M J Torres; A Romano; G Celik; P Demoly; D A Khan; E Macy; M Park; K Blumenthal; W Aberer; M Castells; A Barbaud
Journal:  Clin Transl Allergy       Date:  2017-03-13       Impact factor: 5.871

Review 7.  What Is New in Occupational Allergic Contact Dermatitis in the Year of the COVID Pandemic?

Authors:  Erica B Lee; Marissa Lobl; Aubree Ford; Vincent DeLeo; Brandon L Adler; Ashley Wysong
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-29       Impact factor: 4.806

Review 8.  Impact in Contact Dermatitis during and after SARS-CoV2 Pandemic.

Authors:  Graziella Babino; Giuseppe Argenziano; Anna Balato
Journal:  Curr Treat Options Allergy       Date:  2022-02-10

9.  In Vitro and Clinical Safety Assessment of the Multiple W/O/W Emulsion Based on the Active Ingredients from Rosmarinus officinalis L., Avena sativa L. and Linum usitatissimum L.

Authors:  Ugne Zlabiene; Juste Baranauskaite; Dalia M Kopustinskiene; Jurga Bernatoniene
Journal:  Pharmaceutics       Date:  2021-05-16       Impact factor: 6.321

10.  The erythema Q-score, an imaging biomarker for redness in skin inflammation.

Authors:  John Frew; Lauren Penzi; Mayte Suarez-Farinas; Sandra Garcet; Patrick M Brunner; Tali Czarnowicki; Jaehwan Kim; Claire Bottomley; Robert Finney; Inna Cueto; Judilyn Fuentes-Duculan; Hanako Ohmatsu; Tim Lentini; Valerie Yanofsky; James G Krueger; Emma Guttman-Yassky; Daniel Gareau
Journal:  Exp Dermatol       Date:  2020-11-30       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.